Health
Host tissue T cells play a previously unappreciated role in acute graft-versus-host disease – News-Medical.net
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer.
Reviewed by Emily Henderson, B.Sc.Aug 28 2020
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer. While this therapy can be life-saving, a major complication is the development of graft-versus-host disease (GVHD), which causes significant morbidity and can be fatal. Before allogenic HSCT, a patient receives a conditioning regimen, chemotherapy design…
-
Noosa News14 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General9 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
General11 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for
-
Noosa News14 hours agoNowhere is growing like this corner of Queensland. It’s changing the political game